Goodpasture syndrome: Selective removal of anti-α3(IV) collagen autoantibodies. A potential therapeutic alternative to plasmapheresis

Experimental Nephrology

Volumn 4, Issue 4, 1996, Pages 205-212

  Boutaud, Ariel A ^a   Kalluri, Raghu ^a   Kahsai, Tesfamichael Z ^a   Noelken, Milton E ^a   Hudson, Billy G ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

3(IV) collagen; Immunoglobulins; Affinity; Goodpasture; Plasmapheresis

Indexed keywords

AUTOANTIBODY; COLLAGEN ANTIBODY; COLLAGEN TYPE 4; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G;

AFFINITY CHROMATOGRAPHY; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HUMAN; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; THERAPY;

ADSORPTION; ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; BLOTTING, WESTERN; CATTLE; CHROMATOGRAPHY, AFFINITY; COLLAGEN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; KIDNEY GLOMERULUS; PLASMAPHERESIS; RECOMBINANT PROTEINS; STAPHYLOCOCCAL PROTEIN A;

EID: 0029784378     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Wilson CB, Holdsworth SR, Neale TJ: Antibasement membrane antibodies in immunologic renal disease. Aust N Z J Med 1981;11: 94.
2. Wilson CB, Holdsworth SR: Anti-glomerular basement membrane (GBM) antibody-induced diseases; Zurukzoglu MPW, Pyrpasopoulos M, Sion M, Zamboulis C (eds): Proceedings of the 8th International Congress of Nephrology. Basel, Karger, 1981, pp 910-916.
3. Wilson CB: Immunologic Diseases of the Lung and Kidney (Goodpasture's Syndrome). New York, McGraw-Hill, 1988, pp 675-682.
4. Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: Structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993;268: 26033-26036.
5. Hudson BG, Kalluri R, Gunwar S, Noelken ME, Mariyama M, Reeders ST: Molecular characteristics of the Goodpasture autoantigen. Kidney Int 1993;43:135-139.
6. Hudson BG, Wieslander J, Wisdom BJ, Noelken ME: Goodpasture syndrome: Molecular architecture and function of basement membrane antigen [published erratum in Lab Invest 1989;61:690]. Lab Invest 1989;61:256-269.
7. Couser WG: Rapidly progressive glomerulonephritis: Classification, pathogenic mechanisms, and therapy. Am J Kidney Dis 1988;11: 449.
8. Lockwood CM, Bowman C, Bakes D, Pressey A, Dash A: Autoimmunity and glomerulonephritis. Adv Nephrol 1987;16:291.
9. Timpl R, Dziadek M: Structure, development and molecular pathology of basement membranes. Int Rev Exp Pathol 1986;29:1.
10. Morrison KE, Germino GG, Reeders ST: Use of polymerase chain reaction to clone and sequence a cDNA encoding the bovine α3 chain of type IV collagen. J Biol Chem 1991;266:34-39.
11. Morrison KE, Mariyama M, Yang-Feng TL, Reeders ST: Sequence and localization of a partial cDNA encoding the human α3 chain of type IV collagen. Am J Hum Genet 1991;49: 545-554.
12. Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A, Pusey CD: Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 1992;89:592-601.
13. Feng L, Xia Y, Tang WW, Wilson CB: Alternative splicing of the NC1 domain of the human α3(IV) collagen gene: Differential expression of mRNA transcripts that predict three protein variants with distinct carboxyl regions. J Biol Chem 1994;269:2342-2348.
14. Bernal D, Quiñones S, Saus J: The human mRNA encoding the Goodpasture antigen is alternatively spliced. J Biol Chem 1993;268: 12090-12094.
15. Butkowski RJ, Langeveld JPM, Wieslander J, Hamilton J, Hudson BG: Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 1987; 262:7874-7877.
16. Butkowski RJ, Wieslander J, Wisdom BJ, Barr JF, Noelken ME, Hudson BG: Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen. J Biol Chem 1985;260:3739-3747.
17. Kalluri R, Gunwar S, Reeders ST, Morrision KC, Mariyama M, Ebner KE, Noelken ME, Hudson BG: Goodpasture syndrome: Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the α3(IV) chain of basement membrane collagen. J Biol Chem 1991;266:24018-24024.
18. Neilson EG, Kalluri R, Sun MJ, Gunwar S, Danoff T, Mariyama M, Myers JC, Reeders ST, Hudson BG: Specificity of Goodpasture autoanibodies for the recombinant noncollagenous domains of human type IV collagen. J Biol Chem 1993;268:8402-8405.
19. Pusey CD, Dash A, Kershaw MJ, Reilly A, Morgan A, Rees AJ, Lockwood CM: A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane. Lab Invest 1987;56:23-31.
20. Wieslander J, Barr JF, Butkowski RJ, Edwards SJ, Bygren P, Heinegard D, Hudson BG: Goodpasture antigen of the glomerular basement membrane: Localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci USA 1984;81:3838-3842.
21. Wieslander J, Bygren P, Heinegard D: Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome. Proc Natl Acad Sci USA 1984;81:1544-1548.
22. Wieslander J, Langeveld J, Butkowski R, Jodlowski M, Noelken M, Hudson BG: Physical and immunochemical studies of the globular domain of type IV collagen. Cryptic properties of the Goodpasture antigen. J Biol Chem 1985; 260:8564-8570.
23. Saus J, Wieslander J, Langeveld JPM, Quiñones S, Hudson BG: Identification of Goodpasture antigen as the α3(IV) chain of collagen IV. J Biol Chem 1988;263:13374-13380.
24. Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG, Hudson BG: Identification of the α3 chain of type IV collagen as the common autoantigen in anti-basement membrane disease and Goodpasture syndrome J Am Soc Nephrol, in press.
25. Lerner RA, Dixon FJ: Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum. J Exp Med 1966;124:431-442.
26. Lerner RA, Glasscock RJ, Dixon FJ: The role of antiglomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967;126:989-1004.
27. Lockwood CM, Boulton-Jones JM, Lowenthal RM, Simpson IJ, Peters DK, Wilson CB: Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis. Br Med J 1975;ii:252-254.
28. Bygren P, Freiburghaus C, Lindholm T, Simonsen O, Thysell H, Wieslander J: Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet 1985;ii: 1295-1296.
29. Freiburghaus C, Larsson L-A, Sundqvist S-B, Nilsson IM, Thysell H, Lindholm T: A summary of five years' clinical experience with extensive removal of immunoglobulins. Plasma Ther Transfus Technol 1986;7:545-550.
30. Gunwar S, Ballester F, Kalluri R, Timoneda J, Chonko AM, Edwards S, Noelken ME, Hudson BG: Glomerular basement membrane. J Biol Chem 1991;266:15318-15324.
31. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970:227:680-685.
32. Burnette WH: Western blotting: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981;112:195-203.
33. Hellmark T, Johansson C, Wieslander J: Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int 1994; 46:823-829.